Find policies, billing codes, payers, states, and providers
HCPCS U0001: CDC 2019 Novel Coronavirus RT-PCR Diagnostic Panel
HCPCS Level II code U0001 designates the CDC 2019 novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel, a molecular test used to detect SARS-CoV-2 RNA. Nationally, this code has been central to pandemic response efforts by enabling standardized billing and tracking for a high-volume diagnostic service critical to case identification, public health surveillance, and clinical decision-making.
Analysis covers major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on payer coverage considerations, common billing modifiers, and operational contexts for laboratories and hospital services. The publication outlines typical sites of service and the clinical applicability of the assay, and highlights what national stakeholders consider when processing claims for this test.
This summary provides benchmarks and policy context relevant to payers and providers, including coding purpose, typical service workflows, and areas where payers and laboratories frequently address coverage, documentation, and claim adjudication. Data not available in the input for specific payer policies, reimbursement rates, or claim-level metrics are noted where applicable.
Customize your policy alerts
Sign up for hcpcs U0001 policy alerts
Get alerted when payer policies referencing U0001 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code U0001 represents the CDC 2019 novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel. This code is used to report laboratory testing that detects the presence of SARS-CoV-2 viral RNA using a real-time reverse transcription polymerase chain reaction (RT-PCR) assay developed by the Centers for Disease Control and Prevention.
Service type: Diagnostic molecular laboratory test (real-time RT-PCR).
Typical site of service: Clinical laboratories, hospital laboratories, public health laboratories, and other certified laboratory facilities performing molecular diagnostic testing.